Dupont Capital Management Corp United Therapeutics Corp Transaction History

Dupont Capital Management Corp

$1.18 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$205.19 - $232.99 $91,514 - $103,913	-446 Reduced 46.22%	519 $114,000
Q1 2023 Apr 28, 2023	SELL	$212.99 - $276.17 $666,019 - $863,583	-3,127 Reduced 76.42%	965 $216,000
Q4 2022 Jan 26, 2023	SELL	$205.95 - $280.43 $62,814 - $85,531	-305 Reduced 6.94%	4,092 $0
Q3 2022 Oct 31, 2022	SELL	$203.3 - $244.17 $147,189 - $176,779	-724 Reduced 14.14%	4,397 $921,000
Q2 2022 Jul 26, 2022	BUY	$174.81 - $241.14 $513,242 - $707,987	2,936 Added 134.37%	5,121 $1.21 Million
Q1 2022 Apr 27, 2022	BUY	$166.16 - $213.96 $1,329 - $1,711	8 Added 0.37%	2,185 $392,000
Q4 2021 Jan 31, 2022	SELL	$184.32 - $216.08 $238,325 - $279,391	-1,293 Reduced 37.26%	2,177 $470,000
Q3 2021 Nov 03, 2021	SELL	$179.86 - $214.88 $156,298 - $186,730	-869 Reduced 20.03%	3,470 $640,000
Q2 2021 Jul 30, 2021	SELL	$170.47 - $211.93 $331,905 - $412,627	-1,947 Reduced 30.97%	4,339 $778,000
Q1 2021 Apr 29, 2021	BUY	$153.94 - $174.85 $232,141 - $263,673	1,508 Added 31.56%	6,286 $1.05 Million
Q4 2020 Jan 28, 2021	BUY	$101.87 - $151.79 $115,418 - $171,978	1,133 Added 31.08%	4,778 $725,000
Q3 2020 Oct 29, 2020	SELL	$99.9 - $121.13 $185,314 - $224,696	-1,855 Reduced 33.73%	3,645 $368,000
Q2 2020 Jul 24, 2020	SELL	$92.74 - $125.82 $29,584 - $40,136	-319 Reduced 5.48%	5,500 $666,000
Q1 2020 Apr 29, 2020	BUY	$79.39 - $115.35 $193,552 - $281,223	2,438 Added 72.11%	5,819 $552,000
Q4 2019 Jan 27, 2020	BUY	$78.31 - $95.34 $29,992 - $36,515	383 Added 12.78%	3,381 $298,000
Q2 2019 Jul 30, 2019	SELL	$76.06 - $120.81 $285,148 - $452,916	-3,749 Reduced 55.57%	2,998 $234,000
Q1 2019 Apr 30, 2019	SELL	$107.15 - $126.84 $47,038 - $55,682	-439 Reduced 6.11%	6,747 $792,000
Q4 2018 Feb 01, 2019	BUY	$101.4 - $128.73 $140,540 - $178,419	1,386 Added 23.9%	7,186 $783,000
Q3 2018 Nov 05, 2018	SELL	$113.81 - $129.46 $29,249 - $33,271	-257 Reduced 4.24%	5,800 $742,000
Q2 2018 Jul 30, 2018	SELL	$101.14 - $118.31 $67,763 - $79,267	-670 Reduced 9.96%	6,057 $685,000
Q1 2018 May 02, 2018	SELL	$107.21 - $151.94 $168,641 - $239,001	-1,573 Reduced 18.95%	6,727 $756,000
Q3 2017 Oct 31, 2017	BUY	$114.6 - $136.81 $951,180 - $1.14 Million	8,300	8,300 $973,000

Others Institutions Holding UTHR

# of Institutions

669

Shares Held

42.8M

Call Options Held

194K

Put Options Held

295K

Black Rock Inc. New York, NY

5.47M
Shares

$2.04 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

4.41M
Shares

$1.64 Billion
0.03% of portfolio
Wellington Management Group LLP Boston, MA

3.17M
Shares

$1.18 Billion
0.2% of portfolio
Avoro Capital Advisors LLC New York, NY

2.86M
Shares

$1.07 Billion
15.42% of portfolio
State Street Corp Boston, MA

2.24M
Shares

$835 Million
0.03% of portfolio

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $17B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Account